702 related articles for article (PubMed ID: 17716505)
41. Fixed-duration multidrug therapy in multibacillary leprosy.
Li HY; Hu LF; Wu PW; Luo JS; Liu XM
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
[TBL] [Abstract][Full Text] [Related]
42. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
De D; Dogra S; Kaur I
Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
[TBL] [Abstract][Full Text] [Related]
43. Dapsone hypersensitivity syndrome with coexisting acute hepatitis E.
Chogle A; Nagral A; Soni A; Agale S; Jamadar Z
Indian J Gastroenterol; 2000; 19(2):85-6. PubMed ID: 10812824
[TBL] [Abstract][Full Text] [Related]
44. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Depasquale G
Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
[No Abstract] [Full Text] [Related]
45. Leprosy: not always an easy diagnosis and often a management challenge.
Manifold R; Marshman G
Australas J Dermatol; 2009 Feb; 50(1):36-40. PubMed ID: 19178490
[TBL] [Abstract][Full Text] [Related]
46. Dapsone syndrome in a Filipino man.
Hortaleza AR; Salta-Ramos NG; Barcelona-Tan J; Abad-Venida L
Lepr Rev; 1995 Dec; 66(4):307-13. PubMed ID: 8637384
[TBL] [Abstract][Full Text] [Related]
47. Dapsone induced pulmonary eosinophilia without cutaneous allergic manifestations--an unusual encounter--a case report.
Arunthathi S; Raju S
Acta Leprol; 1998; 11(1):3-5. PubMed ID: 9693685
[TBL] [Abstract][Full Text] [Related]
48. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
49. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
Pandey A; Uddin MJ; Patel R
Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
[TBL] [Abstract][Full Text] [Related]
50. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
Ng PP; Goh CL
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
[No Abstract] [Full Text] [Related]
51. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
52. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
[TBL] [Abstract][Full Text] [Related]
53. Feasibility of multidrug therapy (MDT) in Hansen's disease in an urban population--Curupaiti State Hospital, Rio de Janeiro, Brazil.
Andrade VL; Marques AB; da Cunha LH; Avelleira JR
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):435-40. PubMed ID: 3655459
[TBL] [Abstract][Full Text] [Related]
54. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
Mane I; Grauwin MY; Cartel JL
Acta Leprol; 1995; 9(3):127-31. PubMed ID: 7631583
[TBL] [Abstract][Full Text] [Related]
55. [Chemotherapy of leprosy. I. Sulfones and sulfonamides].
Leiker DL
Ned Tijdschr Geneeskd; 1979 Jun; 123(23):969-72. PubMed ID: 460449
[No Abstract] [Full Text] [Related]
56. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
[TBL] [Abstract][Full Text] [Related]
57. [Long-term effect of leprosy control in both highly endemic prefectures, Weifang of Shandong and Wenshan of Yunnan].
Li H; Weng X; Li T
Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):333-7, 381-2. PubMed ID: 7553142
[TBL] [Abstract][Full Text] [Related]
58. Antileprosy drugs, pregnancy and fetal outcome.
Bhargava P; Kuldeep CM; Mathur NK
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
[No Abstract] [Full Text] [Related]
59. Short-course multi-drug therapy for leprosy patients.
Puavilai S; Timpatanapong P
J Med Assoc Thai; 1989 Jan; 72(1):33-6. PubMed ID: 2656897
[TBL] [Abstract][Full Text] [Related]
60. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
Queiroz RH; Melchior Júnior E; de Souza AM; Gouveia E; Barbosa JC; de Carvalho D
Pharm Acta Helv; 1997 Sep; 72(4):209-13. PubMed ID: 9372643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
